Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Second-Chance Placement of Hemodialysis Patients After Involuntary Discharge for Disruptive Behavior.

Allon M, Thornley-Brown D, Rizk DV, Carrasquillo AJ.

Am J Kidney Dis. 2019 Jun 26. pii: S0272-6386(19)30775-9. doi: 10.1053/j.ajkd.2019.05.008. [Epub ahead of print]

PMID:
31255333
2.

Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.

Guan M, Keaton JM, Dimitrov L, Hicks PJ, Xu J, Palmer ND, Ma L, Das SK, Chen YI, Coresh J, Fornage M, Franceschini N, Kramer H, Langefeld CD, Mychaleckyj JC, Parekh RS, Post WS, Rasmussen-Torvik LJ, Rich SS, Rotter JI, Sedor JR, Thornley-Brown D, Tin A, Wilson JG, Freedman BI, Bowden DW, Ng MCY; FIND Consortium.

Hum Genomics. 2019 May 15;13(1):21. doi: 10.1186/s40246-019-0205-7.

3.

A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis.

Vincenti F, Fervenza FC, Campbell KN, Diaz M, Gesualdo L, Nelson P, Praga M, Radhakrishnan J, Sellin L, Singh A, Thornley-Brown D, Veronese FV, Accomando B, Engstrand S, Ledbetter S, Lin J, Neylan J, Tumlin J; Focal Segmental Glomerulosclerosis Study Group.

Kidney Int Rep. 2017 Apr 7;2(5):800-810. doi: 10.1016/j.ekir.2017.03.011. eCollection 2017 Sep.

4.

Selecting SNPs informative for African, American Indian and European Ancestry: application to the Family Investigation of Nephropathy and Diabetes (FIND).

Williams RC, Elston RC, Kumar P, Knowler WC, Abboud HE, Adler S, Bowden DW, Divers J, Freedman BI, Igo RP Jr, Ipp E, Iyengar SK, Kimmel PL, Klag MJ, Kohn O, Langefeld CD, Leehey DJ, Nelson RG, Nicholas SB, Pahl MV, Parekh RS, Rotter JI, Schelling JR, Sedor JR, Shah VO, Smith MW, Taylor KD, Thameem F, Thornley-Brown D, Winkler CA, Guo X, Zager P, Hanson RL; FIND Research Group.

BMC Genomics. 2016 May 4;17:325. doi: 10.1186/s12864-016-2654-x.

5.

Dialysate content and risk of sudden cardiac death.

Thornley-Brown D, Saha M.

Curr Opin Nephrol Hypertens. 2015 Nov;24(6):557-62. doi: 10.1097/MNH.0000000000000177. Review.

PMID:
26406807
6.

Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).

Iyengar SK, Sedor JR, Freedman BI, Kao WH, Kretzler M, Keller BJ, Abboud HE, Adler SG, Best LG, Bowden DW, Burlock A, Chen YD, Cole SA, Comeau ME, Curtis JM, Divers J, Drechsler C, Duggirala R, Elston RC, Guo X, Huang H, Hoffmann MM, Howard BV, Ipp E, Kimmel PL, Klag MJ, Knowler WC, Kohn OF, Leak TS, Leehey DJ, Li M, Malhotra A, März W, Nair V, Nelson RG, Nicholas SB, O'Brien SJ, Pahl MV, Parekh RS, Pezzolesi MG, Rasooly RS, Rotimi CN, Rotter JI, Schelling JR, Seldin MF, Shah VO, Smiles AM, Smith MW, Taylor KD, Thameem F, Thornley-Brown DP, Truitt BJ, Wanner C, Weil EJ, Winkler CA, Zager PG, Igo RP Jr, Hanson RL, Langefeld CD; Family Investigation of Nephropathy and Diabetes (FIND).

PLoS Genet. 2015 Aug 25;11(8):e1005352. doi: 10.1371/journal.pgen.1005352. eCollection 2015 Aug.

7.

Nephrotoxic effects of common and emerging drugs of abuse.

Pendergraft WF 3rd, Herlitz LC, Thornley-Brown D, Rosner M, Niles JL.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1996-2005. doi: 10.2215/CJN.00360114. Epub 2014 Jul 17. Review. Erratum in: Clin J Am Soc Nephrol. 2019 Apr 5;14(4):586.

8.

Quality of life and outcomes in African Americans with CKD.

Porter A, Fischer MJ, Wang X, Brooks D, Bruce M, Charleston J, Cleveland WH, Dowie D, Faulkner M, Gassman J, Hiremath L, Kendrick C, Kusek JW, Norris KC, Thornley-Brown D, Greene T, Lash JP; AASK Study Group.

J Am Soc Nephrol. 2014 Aug;25(8):1849-55. doi: 10.1681/ASN.2013080835. Epub 2014 Apr 3.

9.

AKI associated with synthetic cannabinoids: a case series.

Bhanushali GK, Jain G, Fatima H, Leisch LJ, Thornley-Brown D.

Clin J Am Soc Nephrol. 2013 Apr;8(4):523-6. doi: 10.2215/CJN.05690612. Epub 2012 Dec 14.

10.

Quality of life and psychosocial factors in African Americans with hypertensive chronic kidney disease.

Porter A, Fischer MJ, Brooks D, Bruce M, Charleston J, Cleveland WH, Dowie D, Faulkner M, Gassman J, Greene T, Hiremath L, Kendrick C, Kusek JW, Thornley-Brown D, Wang X, Norris K, Unruh M, Lash J.

Transl Res. 2012 Jan;159(1):4-11. doi: 10.1016/j.trsl.2011.09.004. Epub 2011 Oct 12.

11.

Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.

Bostrom MA, Kao WH, Li M, Abboud HE, Adler SG, Iyengar SK, Kimmel PL, Hanson RL, Nicholas SB, Rasooly RS, Sedor JR, Coresh J, Kohn OF, Leehey DJ, Thornley-Brown D, Bottinger EP, Lipkowitz MS, Meoni LA, Klag MJ, Lu L, Hicks PJ, Langefeld CD, Parekh RS, Bowden DW, Freedman BI; Family Investigation of Nephropathy and Diabetes (FIND) Research Group.

Am J Kidney Dis. 2012 Feb;59(2):210-21. doi: 10.1053/j.ajkd.2011.09.020. Epub 2011 Nov 25.

12.

Elevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease.

Fischer MJ, Kimmel PL, Greene T, Gassman JJ, Wang X, Brooks DH, Charleston J, Dowie D, Thornley-Brown D, Cooper LA, Bruce MA, Kusek JW, Norris KC, Lash JP; AASK Study Group.

Kidney Int. 2011 Sep;80(6):670-8. doi: 10.1038/ki.2011.153. Epub 2011 Jun 1.

13.

Sociodemographic factors contribute to the depressive affect among African Americans with chronic kidney disease.

Fischer MJ, Kimmel PL, Greene T, Gassman JJ, Wang X, Brooks DH, Charleston J, Dowie D, Thornley-Brown D, Cooper LA, Bruce MA, Kusek JW, Norris KC, Lash JP; AASK study group.

Kidney Int. 2010 Jun;77(11):1010-9. doi: 10.1038/ki.2010.38. Epub 2010 Mar 3.

14.

Genome-wide linkage scans for type 2 diabetes mellitus in four ethnically diverse populations-significant evidence for linkage on chromosome 4q in African Americans: the Family Investigation of Nephropathy and Diabetes Research Group.

Malhotra A, Igo RP Jr, Thameem F, Kao WH, Abboud HE, Adler SG, Arar NH, Bowden DW, Duggirala R, Freedman BI, Goddard KA, Ipp E, Iyengar SK, Kimmel PL, Knowler WC, Kohn O, Leehey D, Meoni LA, Nelson RG, Nicholas SB, Parekh RS, Rich SS, Chen YD, Saad MF, Scavini M, Schelling JR, Sedor JR, Shah VO, Taylor KD, Thornley-Brown D, Zager PG, Horvath A, Hanson RL; Family Investigation of Nephropathy and Diabetes Research Group.

Diabetes Metab Res Rev. 2009 Nov;25(8):740-7. doi: 10.1002/dmrr.1031.

15.

Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy.

Weinberg JM, Appel LJ, Bakris G, Gassman JJ, Greene T, Kendrick CA, Wang X, Lash J, Lewis JA, Pogue V, Thornley-Brown D, Phillips RA; African American Study of Hypertension and Kidney Disease Collaborative Research Group.

Arch Intern Med. 2009 Sep 28;169(17):1587-94. doi: 10.1001/archinternmed.2009.284.

PMID:
19786678
16.

The effect of peritoneal dialysate on DXA bone densitometry results in patients with end-stage renal disease.

Mann ML, Thornley-Brown D, Campbell R, Bell E, Burroughs L, Nunnally N, Feng R, Morgan SL.

J Clin Densitom. 2008 Oct-Dec;11(4):532-6. doi: 10.1016/j.jocd.2008.08.103. Epub 2008 Sep 21.

PMID:
18809346
17.

MYH9 is associated with nondiabetic end-stage renal disease in African Americans.

Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Tandon A, Powe NR, Fink NE, Sadler JH, Weir MR, Abboud HE, Adler SG, Divers J, Iyengar SK, Freedman BI, Kimmel PL, Knowler WC, Kohn OF, Kramp K, Leehey DJ, Nicholas SB, Pahl MV, Schelling JR, Sedor JR, Thornley-Brown D, Winkler CA, Smith MW, Parekh RS; Family Investigation of Nephropathy and Diabetes Research Group.

Nat Genet. 2008 Oct;40(10):1185-92. doi: 10.1038/ng.232. Epub 2008 Sep 14.

18.

Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans.

Lea J, Cheek D, Thornley-Brown D, Appel L, Agodoa L, Contreras G, Gassman J, Lash J, Miller ER 3rd, Randall O, Wang X, McClellan W; AASK Study Investigators.

Am J Kidney Dis. 2008 May;51(5):732-40. doi: 10.1053/j.ajkd.2008.01.013. Epub 2008 Mar 20.

PMID:
18436083
19.

Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease.

Thornley-Brown D, Wang X, Wright JT Jr, Randall OS, Miller ER, Lash JP, Gassman J, Contreras G, Appel LJ, Agodoa LY, Cheek D.

Arch Intern Med. 2006 Apr 10;166(7):797-805.

PMID:
16606818
20.
21.

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER 3rd, Norris K, O'Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT Jr, Xu S; African American Study of Kidney Disease and Hypertension (AASK) Study Group.

JAMA. 2001 Jun 6;285(21):2719-28.

PMID:
11386927
22.

Extraskeletal calcification in patients with chronic kidney failure.

Drüeke TB, Touam M, Thornley-Brown D, Rostand SG.

Adv Nephrol Necker Hosp. 2000;30:333-56. Review. No abstract available.

PMID:
11068650
23.

Homocysteine elevation in sickle cell disease.

Lowenthal EA, Mayo MS, Cornwell PE, Thornley-Brown D.

J Am Coll Nutr. 2000 Oct;19(5):608-12.

PMID:
11022874
24.

Reactive species in sickle cell disease.

Aslan M, Thornley-Brown D, Freeman BA.

Ann N Y Acad Sci. 2000;899:375-91. Review.

PMID:
10863554
25.

A case study of a recent decline in the dialysis fatality rate.

Pollak VE, Thornley-Brown D, Kant KS, Pesce A, Deddens JA.

Contrib Nephrol. 1993;102:59-72.

PMID:
8416189
26.

Lithium toxicity associated with a trichobezoar.

Thornley-Brown D, Galla JH, Williams PD, Kant KS, Rashkin M.

Ann Intern Med. 1992 May 1;116(9):739-40. No abstract available.

PMID:
1558346
27.

Peritonitis due to Aspergillus niger: diagnostic importance of peritoneal eosinophilia.

Sridhar R, Thornley-Brown D, Kant KS.

Perit Dial Int. 1990;10(1):100-1. No abstract available.

PMID:
2085565
28.

Acetazolamide inhibition of renal gamma-glutamyl transpeptidase.

Thornley-Brown D, Dass PD, Welbourne TC.

Biochem Pharmacol. 1982 Nov 1;31(21):3347-52.

PMID:
6128982

Supplemental Content

Loading ...
Support Center